Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 911 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
8 Мб
Скачать
316
https://t.me/medicina_free
47. Weiner E, Bar J, Fainstein N, et al. e eect of a program to shorten the decision- to- delivery interval for emergent cesarean section on maternal and neonatal outcome. Am J Obstet Gynecol. 2014;210(3):224.e1– 6.
48. Balki M, Chakravarty S, Salman A, Wax RS. Eectiveness of using high- delity simulation to teach the management of general anes­thesia for Cesarean delivery. Can J Anaesth. 2014;61(10):922– 34. Epub 2014 Jul29.
49. Ortner CM, Richebé P, Bollag LA, Ross BK, Landau R. Repeated simulation- based training for performing general anesthesia for emergency cesarean delivery:long- term retention and recurring mis­takes. Int J Obstet Anesth. 2014;23(4):341– 7. Epub 2014May4.
50. Pratt SD. Focused review:simulation in obstetric anesthesia. Anesth Analg. 2012;114(1):186– 90. Epub 2011 Oct24.
51. Daniels K, Arafeh J, Clark A, Waller S, Druzin M, Chueh J. Prospective randomized trial of simulation versus didactic teaching for obstetrical emergencies. Simul Healthc. 2010;5(1):40– 5.
52. Maslovitz S, Barkai G, Lessing JB, Ziv A, Many A. Recurrent obstet­ric management mistakes identied by simulation. Obstet Gynecol. 2007;109(6):1295– 300.
53. Guise JM, Lowe NK, Deering S, et al. Mobile in situ obstet­ric emergency simulation and teamwork training to improve maternal- fetal safety in hospitals. Jt Comm J Qual Patient Saf. 2010;36(10):443– 53.
54. Sørensen JL, Van der Vleuten C, Lindschou J, etal. “In situ simula­tion” versus “o site simulation” in obstetric emergencies and their eect on knowledge, safety attitudes, team performance, stress, and
motivation:study protocol for a randomized controlled trial. Trials. 2013;17(14):220.
55. Sørensen JL, Lottrup P, van der Vleuten C, Andersen KS, Simonsen M, Emmersen P, Rosthøj S, Ottesen B. Unannounced in situ simula­tion of obstetric emergencies:sta perceptions and organisational impact. Postgrad Med J. 2014;90(1069):622– 9. Epub 2014 Sep10.
56. Sweeney J, Maietta R, Olson K. An analysis comparing “Sim Huddles” to traditional simulation for obstetric emergency pre­paredness. Nurs Womens Health. 2015;19(1):16– 25.
57. Ryding EL, Wijma B, Wijma K. Posttraumatic stress reactions aer emergency cesarean section. Acta Obstet Gynecol Scand. 1997;76(9):856– 61.
58. Ryding EL, Wijma K, Wijma B. Predisposing psychological factors for posttraumatic stress reactions aer emergency cesarean section. Acta Obstet Gynecol Scand. 1998;77(3):351– 2.
59. Ryding EL, Wijma K, Wijma B. Experiences of emergency cesar­ean section: a phenomenological study of 53 women. Birth. 1998;25(4):246– 51.
60. am V, Christensson K, Ryding EL. Sense of coherence and symp­toms of post- traumatic stress aer emergency caesarean section. Acta Obstet Gynecol Scand. 2007;86(9):1090– 6.
61. am V, Ryding EL, Christensson K. Experience of support among mothers with and without post- traumatic stress symp­toms following emergency caesarean section. Sex Reprod Healthc. 2010;1(4):175– 80. Epub 2010 Jul23.
62. Reynolds JL. Post- traumatic stress disorder aer childbirth:the phe­nomenon of traumatic birth. CMAJ. 1997;156(6):831– 5.
316 SECTION A. MATERNAL COLLAPSE
https://t.me/medicina_free
317
SECTIONB
CARDIACCRISES
318
https://t.me/medicina_free
https://t.me/medicina_free
319
45.
HIGH OR TOTAL SPINAL/ EPIDURAL
Feyce Peralta
CLINICALCASE
addition patients may have symptoms of post- traumatic stress
disorder depending on the events that occurred during the A 27- year- old laboring patient, G1P0 at 41 weeks estimated gestational age, admitted for induction of labor, is being transported from a labor and delivery room to the operat­ing room for cesarean delivery secondary to arrest of dila­tion. She has a functional labor epidural catheter in place, which is being dosed in route to the operating room for sur­gical anesthesia. Afew minutes aer arrival in the operat­ing room the patient complains of diculty breathing and bilateral hand weakness.
time they were unable to communicate or move. Just as com-
munication is crucial during the event, debrieng aerward
and oering access to counseling can be benecial.
If maternal hemodynamics are signicantly compro­mised due to a high block level, uteroplacental perfusion can be compromised, leading to fetal heart rate decelera­tions and potentially the need for emergency delivery. In the case of suspected high/ total neuraxial block, fetal heart tones should be monitored while the patient is stabilized and preparation made for expedient delivery. In the case
DEFINITION
High spinal/ epidural occurs when a neuraxial block spreads well above the dermatomal level required for a surgical
of unresolving fetal bradycardia, crash cesarean delivery should be performed in the usual manner.
INCIDENCE
procedure. is can be acceptable if the patient remains asymptomatic or only mildly symptomatic (i.e., only upper­extremity numbness). However, it can be associated with respiratory compromise and hemodynamic instability (e.g., bradycardia, hypotension) from blockade of the sympa­thetic system, leading to drastic vasodilation and inhibition of cardioaccelerator bers. Total spinal or epidural block­ade relates to an anesthetic block that causes loss of con­sciousness and respiratory arrest secondary to central action at the level of the cervical spine and brainstem. e latter requires intubation for respiratory support, conversion to general anesthesia, and supportive measures until the block recedes. Because there is a ne line between high and total
e true incidence of high or total spinal/ epidural has been dicult to elucidate because of the rarity of these events and the variations in the denitions used for these two complications:high versus total spinal/ epidural.
2,3
e Serious Complication Repository (SCORE) Project was a study conducted to establish the incidence of serious com­plications related to obstetric anesthesia. In this study of more than 160,000 epidural and combined spinal epidural, a high neuraxial block (dened as neuraxial block necessi­tating intubation or conversion to general anesthesia) was found to be the most frequent serious complication related to neuraxial anesthesia, occurring in 1:4,336 anesthetics.
4
spinal/ epidural, and the management is similar, related studies discuss them as one entity.
PATHOPHYSIOLOGY OFDISEASESTATE
COMPLICATIONS
In a 2009 obstetric anesthesia closed claims analysis the most common anesthetic cause of maternal death/ brain damage in regional anesthesia claims was high neuraxial block (22%).1 In
It is important to understand the mechanism of disease and risk factors for high spinal in order to appropriately con­sider this etiology, recognize the presence of the hemody­namic derangements of high/ total spinal, and immediately begin treatment.
319
320
https://t.me/medicina_free
MECHANISM
A high or total neuraxial block (spinal or epidural) occurs aer the injection of local anesthetic in the epidural, subdu­ral, or intrathecal space that spreads higher than intended, involving at least the cardioaccelerator bers at T1- 4. us, the local anesthetic may directly block neural conductivity or otherwise interfere with neuronal function in the cervi­cal spine and brainstem while producing a sympathectomy below that level. However, the most frequent cause of frank respiratory arrest during high neuraxial block is brainstem hypoperfusion secondary to signicant systemic hypoten­sion and decreased cardiac output. In the case of high/ total spinal aer epidural catheter dosing, this can be due to unintentional epidural catheter placement into the subdu­ral or intrathecal space or catheter migration to one of these spaces during labor.
5
RISK
In the SCORE project the most common risk factors for the development of a high or total spinal/ epidural were obesity (41%) and the administration of spinal anesthetic aer a failed epidural anesthetic (27%). Other risk factors included height <60 inches, epidural aer unintentional dural puncture, and spinal deformity.
e incidence of unrecognized spinal catheters was 24%. Ninety- four percent (or 1:12,000 labor epidurals) of the unrecognized spinal catheters that resulted in a high neuraxial block occurred in the labor suite as opposed to
TABLE45.1 RISK FACTORS FORHIGH NEURAXIALBLOCK
Category Factor Description
Medication Factors Large dose of high concentration local
anesthetic
Isobaric solution (vs. hyperbaric)
Prior drug administration in intrathecal space (followed by large epidural dose)
Patient Factors Increased abdominal pressure (i.e., obesity,
pregnancy) with resultant increased epidural fat and volume of epidural venous plexus
Spinal deformity
Height (<60cm)
Technique Factors Epidural after unintentional dural puncture
with large bore needle
Immediate supine position
Higher lumbar position
vasopressors are the mainstays of management of these patients. While phenylephrine is usually the rst- line vaso­pressor during pregnancy, in bradycardic and hypotensive patients epinephrine is the preferred treatment, starting with small doses (~25– 50 mcg IV) and increasing with each additional dose every 30– 90 seconds until hemodynamic stability is achieved. Although it may seem counterintuitive to supporting hemodynamics, the reverse Trendelenburg position may help prevent further block spread.
the operating room (95% CI, 1:7,194 to 1:20,842) (See Table45.1).
ASSESSMENT OFTHE PATIENT
BOX 45.1 SYMPTOMS OFHIGH/ TOTAL NEURAXIAL
BLOCKADE
Nausea/ vomiting
Symptoms typically present immediately following spinal anesthetic administration, and within minutes aer initial dosing of an epidural catheter or aer redosing a preexisting epidural catheter. Common symptoms associated with high and total spinal are presented in Box45.1.
INITIAL TREATMENTSTEPS
Treatment consists of immediate support of ventilation and blood pressure. Depending on the extent of the block rise, oxygen supplementation can be delivered via facemask or intubation. Administration of intravenous uids and
320 SECTION B. CARDIAC CRISES
Anxiety
Difculty speaking/ swallowing/ coughing
Loss of handgrip
Hypotension
Bradycardia
Paralysis
Respiratory compromise/ respiratoryarrest
Loss of consciousness
Cardiacarrest
https://t.me/medicina_free
321
SUBSEQUENT TREATMENTSTEPS
Communication with the patient is paramount, and admin­istration of sedative hypnotics should be considered aer hemodynamic stability is achieved if the patient expresses anxiety or dyspnea related to weakness. In this instance the patient might be unable to move or speak while still main­taining alertness. Patients who will be intubated require induction medications to ensure amnesia for the event. Supportive measures should be maintained until the block has receded to approximately the T2- 4 level to ensure ade-
FOLLOW- UP
Assessment of vital signs, neurologic status, and dermato­mal regression of sensory and motor blocks should be done for patients who experience a high spinal/ epidural block prior to patient’s discharge to the postpartum oor. is can be done in the recovery room or the intensive care unit, depending on the resources available.
Equally important is a follow- up conversation with the
patient to disclose the occurrences that possibly led to these
8
events. quate cardiac and respiratory dynamics. is should occur in a period of 30 minutes to 1 hour, but depending on the contributing factors the time frame could be shorter or lon-
CONCLUSION
ger. If a true high or total neuraxial block occurs, resulting in neurogenic shock, the provider should be prepared to start an infusion for chronotropic support until the block recedes.
High or total neuraxial block is rare, but is associated with
maternal complications if not rapidly treated. Symptoms
include initial nausea and vomiting that are quickly fol-
lowed by hemodynamic instability, particularly bradycar-
dia and hypotension, and oen respiratory compromise.
PREVENTION
The negative aspiration of cerebral spinal fluid and a
Treatment is supportive and denitive resolution depends
only on time. Patients should be counseled aer the fact
regarding likely inciting factors.
negative test dose do not guarantee correct location of an epidural catheter.1 The aspiration portion is espe­cially true when single- orifice catheters are used, and after long periods of time with the epidural catheter in place. The best practice would include a combination of catheter aspiration + test dose administration via the catheter at the time of placement. Subsequently, each time the catheter is accessed, the provider should start with a small dose of local anesthetic ( +/ - epinephrine) that acts as a secondary test dose. Once proven negative, incremental doses of local anesthetics (e.g., 3- 5 mL at a time) coupled with frequent patient assessments can fol­low provided a nonemergent situation.
6
In the setting of dysfunctional epidural catheter anal-
CASE- BASED LEARNING DISCUSSION
1. How would you dose the existing epidural catheter for surgical anesthesia? Which drugs would youuse?
2. In the case presented, what would be part of your dierential diagnosis?
3. How will you treat this patient? If the symptoms do not progress, does she require intubation? Will you give her sedation?
4. How will you counsel her aer the current issue resolves?
gesia with an existing residual block and an indication for nonemergent cesarean delivery, replacement of the existing epidural catheter with a combined- spinal epidural (reduce
REFERENCES
spinal dose by 20% to 30%) or a de novo epidural catheter titrated to eect have both been suggested as alternatives to general anesthesia. Single- shot spinal anesthesia should only be considered aer residual block wears o and aer waiting at least 30 minutes aer last epidural bolus admin­istrations.7 Labor epidural catheters that appear to be dysfunctional or when a small bolus dose results an over­exaggerated block response should be replaced in a timely manner during the labor process.
1. Davies JM, Posner KL, Lee LA, Cheney FW, Domino KB. Liability
associated with obstetric anesthesia: a closed claims analysis. Anesthesiology. 2009;110:131– 9.
2. Hawkins JL, Chang J, Palmer SK, Gibbs CP, Callaghan WM.
Anesthesia- related maternal mortality in the United States:1979-
2002. Obstetrics and Gynecology. 2011;117:69– 74.
3. Paech MJ, Godkin R, Webster S. Complications of obstetric epi-
dural analgesia and anaesthesia: a prospective analysis of 10,995 cases. Int J Obstet Anesth. 1998;7:5– 11.
4. D’Angelo R, Smiley RM, Riley ET, Segal S. Serious complications
related to obstetric anesthesia:the serious complication repository
HIGH OR TOTAL SPINAL/EPIDURAL 321
322
https://t.me/medicina_free
project of the Society for Obstetric Anesthesia and Perinatology. Anesthesiology. 2014;120:1505– 12.
5. Pan PH, Bogard TD, Owen MD. Incidence and characteris­tics of failures in obstetric neuraxial analgesia and anesthesia: a retrospective analysis of 19,259 deliveries. Int J Obstet Anesth. 2004;13:227– 33.
6. Gaiser RR. e epidural test dose in obstetric anesthesia: it is not obsolete. J Clin Anesth. 2003;15:474– 7.
7. Portnoy D, Vadhera RB. Mechanisms and management of an incomplete epidural block for cesarean section. Anesthesiol Clin North America. 2003;21:39– 57.
8. Weiss PM, Miranda F. Transparency, apology and disclo­sure of adverse outcomes. Obstet Gynecol Clin North Am. 2008;35:53– 62,viii.
322 SECTION B. CARDIAC CRISES
https://t.me/medicina_free
323
46.
PERIPARTUM CARDIOMYOPATHY
Emily J.Baird
CLINICALCASE
PPCM. e prevalence of PPCM is signicantly higher
in developing countries such as Nigeria (1:100)2 and Haiti A 28- year- old African American female presents 4days post­partum complaining of fatigue, dyspnea, and chest pres­sure. Physical exam reveals elevated jugular venous pressure, displaced apical impulse, pulmonary rales, and peripheral edema. Chest x- ray demonstrates an enlarged cardiac silhou­ette, pulmonary venous congestion, and interstitial inltrates. Echocardiogram is signicant for globally decreased contrac­tility with an ejection fraction (EF) of 35% and a le ventricu­lar end- diastolic dimension (LVEDD) of 3.2cm/ m2. Of note, the patient has no history of cardiac disease and her intrapar­tum course was uneventful.
(1:300)3 compared to industrialized countries, including
South Africa (1:1,000)4 and the United States (1:,3000).5 e
high incidence in Nigeria may be related to a local Hausa cus-
tom of eating kanwa, a dry lake salt for 40days aer delivery.2
Within the United States, African American women are 3 to
16 times more likely to be diagnosed with PPCM.6 Finally,
the majority of PPCM cases in the United States are associ-
ated with low parity, with 40% of patients diagnosed during
a rst pregnancy and 50% identied within their rst two
pregnancies.7 Elucidation of the pathophysiologic mechanism
of PPCM will hopefully provide further insight into the geo-
graphic and racial variations.
INTRODUCTION
PATHOPHYSIOLOGY OFDISEASEDSTATE
Peripartum cardiomyopathy (PPCM) is an idiopathic form of heart failure that manifests during the last month of pregnancy or the rst 5months postpartum. Although the incidence is relatively low, the maternal impact is high, with up to 12% of maternal deaths in the United States result­ing from sequelae of PPCM.1 Despite research eorts, risk factors for PPCM are poorly characterized and the patho­physiologic mechanism remains incompletely understood. Timely diagnosis continues to be a challenge, since many of the symptoms of PPCM mimic those commonly encoun­tered during the normal peripartum period. Management of PPCM parallels current heart failure guidelines, with special consideration to the safety of medications and interventions during pregnancy and lactation. e clinical course of PPCM varies between complete recovery to rapid progression with end- stage heart failure and evendeath.
e pathophysiology of PP CM remains nebulous. Although
numerous potential inciting events have been investigated,
no single factor has been unambiguously identied as the
underlying etiology of PPCM. e most probable causes
of PPCM include inammation, immune- mediated injury,
and/ or genetic contributions. High concentrations of
serum inammatory markers in PPCM patients, includ-
ing tumor necrosis factor- α (TNF- α), C reactive protein
(CRP), interferon- γ (IF- γ), and interleukin- 6 (IL- 6), sug-
gest an underlying inammatory process.
8,9
Furthermore, myocardial biopsies have found histological evidence of myocarditis in 9%– 62% of patients with PPCM.10 Although there is certainly an association between inam­mation and PPCM, it is unclear whether the relationship is causative or reactive. e maternal immune system is another potential cause of peripartum cardiac injury. Fetal
EPIDEMIOLOGY
cells introduced into the maternal circulation may interact with cardiac tissue, triggering a pathologic autoimmune response directed at the maternal cardiac tissue. Although
Environmental, genetic, cultural, and obstetric factors may account for the wide variation in the reported incidence of
a maternal immune- mediated injury is certainly plausible, available data is contradictory and insucient to establish
323
324
https://t.me/medicina_free
Pituitary Gland Placenta
Bromocriptine
sFLT-1
23 kDa Prolactin 16 kDa Prolactin
Cathepsin-D
VEGF
Reactive Oxygen Species
(ROS)
Manganese Sodium Dismutase
Figure46.1 Proposed pathophysiology of PPCM. Decreased concentration of STAT3 causes an increased expression of manganese sodium dismutase
(MnSOD). Decreased MnSOD leads to an increase in reactive oxygen species (ROS), which promotes activation of cathepsin D.Cathepsin D catalyzes the cleavage of prolactin (PRL) to its 16 kDa form. The antiangiogenic activities of 16 kDa PRL and soluble fms- like tyrosine kinase 1 (sFLT1) overcome the proangiogenic activities of vascular endothelial growth factor (VEGF), leading to increased endothelial cell apoptosis and cardiomyocyte dysfunction.
whether an abnormal immunological response is the cause of PPCM.
10,11
Finally, a susceptible genetic background superimposed on the physiologic stress of pregnancy may lead to unmasking of latent idiopathic dilated cardiomyop­athy (DCM).
11,12
Previous studies have identied an associ­ation with the occurrence of PPCM and a familial history of DCM.13 Although the etiology remains unclear, recent evidence suggests PPCM is the result of a common nal pathway involving enhanced oxidative stress leading to an imbalance in angiogenic signaling (Figure 46.1).
(MnSOD)
STAT3
Cardiomyocte
14– 17
normal physiologic perturbations during the peripartum period. Clinical manifestations commonly develop within the rst 2months following delivery, with less than 10% of cases occurring in the antepartum period.
18,19
Symptoms, including dyspnea, orthopnea, palpitations, and chest pres­sure, are consistent with those experienced in all forms of heart failure and are not pathognomonic for PPCM. Other nonspecic symptoms frequently endorsed include fatigue, malaise, and abdominal discomfort. Physical exam ndings include signs of both right and le heart failure such as tachycardia, elevated jugular venous pressure, dis-
DIAGNOSIS OFPPCM
Once the mechanism of disease and risk factors have been understood, recognizing the clinical presentation is key to being able to diagnose and treat this serious condition in
placed apical impulse, third heart sound, systolic murmur of tricuspid or mitral regurgitation, pulmonary rales, and peripheraledema.
DIAGNOSTIC CRITERIA
the peripartum period.
e diagnosis of PPCM, as previously dened by the
CLINICAL PRESENTATION
e presentation of PPCM can be insidious. Diagnosis is frequently delayed due to the overlap of symptoms with
National Institutes of Health, is based on four criteria20: (1) Heart failure develops within a 6- month period span­ning from the last month of pregnancy to 5 months post­partum; (2) ere are no other identiable causes for
324 SECTION B. CARDIAC CRISES
https://t.me/medicina_free
325
Symptoms of PPCM
• Dyspnea
• Orthopnea
• Palpitations
• Chest pressure
• Fatigue
• Malaise
Normotensive Hypotensive Hypertensive
Signs of PPCM
• JVD
• Pulmonary rales
• Tachypnea
• Tachycardia
• Third heart sound
• New murmur
• Peripheral edema
Clinical History
• Symptoms of heart failure?
• Onset of symptoms within last month of pregnancy or 5 months postpartum?
• No previous history of cardiac disease?
Yes
Physical Exam
Signs of heart failure?
YesYes
Yes
Echocardiogram
LVEF 45%
Supportive Studies
• CXR
• ECG
• Labs
Yes
Yes
Yes
No
No
Consider Alternative Diagnosis
LVEF > 45%
Possible Adjunct Studies
• Cardiac MRI
• Myocardial biopsy
• Cardiac catheterization
Yes
Consider Alternative Diagnosis
Yes
Consider Alternative Diagnosis
Consider Alternative Diagnosis
Alternative Diagnosis
• Preeclampsia
• Pulmonary embolism
• Myocardial infarction
• Amniotic fluid embolism
• Severe anemia
Figure46.2 Algorithm for the diagnosis ofPPCM.
the cardiomyopathy; (3) e patient does not have a prior history of congenital or acquired cardiac disease; and (4) Echocardiogram ndings demonstrate a dilated cardiomyopathy with an EF < 45% and/ or M- mode frac­tional shortening < 30% and a LVEDD > 2.7 cm/ m2. erefore, PPCM is a diagnosis of exclusion. Other causes of cardiac dysfunction, including pulmonary embolism, systemic infection, hypertensive disorders, severe anemia, and acquired or congenital heart disease, must be ruled out before the diagnosis of PPCM can be assigned (Figure 46.2).
tachycardia, nonspecic ST- and T- wave changes, le ven­tricular (LV) hypertrophy, and/ or LV conduction defects. New- onset atrial and/ or ventricular arrhythmias may be noted. e ECG is also helpful in excluding conditions in
18,21
the dierential diagnosis such as myocardial infarction and pulmonary embolism. e CXR may reveal an enlarged cardiac silhouette, pulmonary venous congestion, and/ or interstitial inltrates. Less commonly, pleural eusions and/ or pericardial eusion can be identied. Fetal shield­ing is necessary if the CXR is performed in the antepartum period. Finally, echocardiogram is essential for the diagno-
SUPPORTING STUDIES
sis of PPCM. e echocardiogram is also useful in identi­fying other cardiac anomalies commonly occurring with
PPCM including decreased right ventricular systolic func­Supporting studies are necessary to exclude other causes of symptomology, denitively diagnosis PPCM, and quantify the extent of heart failure.
10– 12
Evaluation should include elec­trocardiogram (ECG), chest x- ray (CXR), echocardiogram, and cardiac protein assays. Other studies that are not routinely recommended for the diagnosis of PPCM, but may be con­sidered if the diagnosis is unclear, including cardiac magnetic resolution imaging (MRI), myocardial biopsy, cardiac cath­eterization, and serum inammatory markers.
No pathognomonic ECG ndings have been identied
for PPCM. e most common ECG changes include sinus
tion, mitral regurgitation, tricuspid regurgitation, mural thrombus, and pericardial eusion.
Cardiac MRI is increasingly being used to conrm and complement echocardiogram ndings in PPCM.10 An MRI is particularly useful in identifying intracardiac thrombus, quantifying cardiac function and structure, and assessing cardiac volumes. And MRI is especially benecial in situations where transthoracic ECG is technically subop­timal due to patient factors. Because MRI does not pose the risk of radiation exposure, serial testing may be performed safely in most PPCM patients. Gadolinium crosses the
PERIPARTUM CARDIOMYOPATHY 325
Соседние файлы в папке @xirurgi_2025